[PDF][PDF] Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a …

IMCM de Kok, J van Rosmalen, J Dillner, M Arbyn… - Bmj, 2012 - bmj.com
… HPV testing over the age of 30.The only cost effective policy in our results with screening
under the age of 30 was primary cytology screening (table 6). In addition, HPV …

Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a …

KT Simms, JF Laprise, MA Smith, JB Lew… - The Lancet Public …, 2016 - thelancet.com
… a change to primary HPV screening, because the cost-effectiveness of HPV9 might be
dependent on the screening programme. However, because the details of primary HPV …

Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study

M Jit, M Brisson, A Portnoy, R Hutubessy - The Lancet Global health, 2014 - thelancet.com
cost effective in most countries and cost-effective in almost every country in the world (panel).
Furthermore, cost effectiveness of … than presented, once further benefits not included in our …

Clinical impact and cost-effectiveness of primary cytology versus human papillomavirus testing for cervical cancer screening in England

I Bains, YH Choi, K Soldan, M Jit - International Journal of Gynecologic …, 2019 - ijgc.bmj.com
… . An evaluation of liquid-based cytology and human papillomavirus testing within the UK
cervical cancer screening programme. Br J Cancer 2004;91:84–91.doi:10.1038/sj.bjc.6601884 …

Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway

EA Burger, JD Ortendahl, S Sy, IS Kristiansen… - British journal of …, 2012 - nature.com
… We evaluated the cost-effectiveness of alternative screening strategies to inform cervical …
a switch to primary HPV testing in older women is expected to be cost-effective compared with …

[HTML][HTML] The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC …

HC Kitchener, K Canfell, C Gilham… - Health Technology …, 2014 - ncbi.nlm.nih.gov
… In Screening To Improve Cytology) trial originally reported after two rounds of primary cervical
screening with human papillomavirus (… HPV test, which could allow extended screening

Cost effectiveness of human papillomavirus-16/18 genotyping in cervical cancer screening

WK Huh, E Williams, J Huang, T Bramley… - … health economics and …, 2015 - Springer
… The aim of this study was to evaluate the cost effectiveness of cervical cancer primary
screening with a HPV-16/18 genotyping test which simultaneously detects 12 other high-risk HPV …

Costeffectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial

I Cromwell, LW Smith, K van Der Hoek… - Cancer …, 2021 - Wiley Online Library
… estimate the costs and effectiveness of using primary HPV testing, vs. primary testing using
… Our results do suggest, however, that screening led by HPV testing does not cost more than …

The cost-effectiveness of human papillomavirus screening for cervical cancer: A review of recent modelling studies

J Holmes, L Hemmett, S Garfield - The European Journal of Health …, 2005 - Springer
screening [1] has focussed renewed attention on the role of human papillomavirus (HPV)
testing in screening … value of HPV testing in primary cervical cancer screening in combination …

Health economic evaluation of primary human papillomavirus screening in urban populations in China

A Keane, JF Shi, KT Simms, YJ Liu, JB Lew… - Cancer …, 2021 - Elsevier
primary testing every 5 years could be cost effective in urban China [53] and that HPV DNA
primary testing every 5 years in combination with vaccination could be cost-effective across …